Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY:DVA)

183.09 -10.77 (-5.56%)
Official Closing Price Updated: 7:00 PM EDT, Sep 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DaVita HealthCare Partner

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
3 Reasons to Sell DVA and 1 Stock to Buy Instead
DaVita’s 20.6% return over the past six months has outpaced the S&P 500 by 7%, and its stock price has climbed to $183.98 per share. This performance may hav... 
Via StockStory
Topics Stocks
News headline image
3 of Wall Street’s Favorite Stocks We Find Risky
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember... 
Via StockStory
News headline image
1 Value Stock with Impressive Fundamentals and 2 Facing Headwinds
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t... 
Via StockStory
Topics Energy
DaVita (NYSE:DVA) Q2 2026: EPS Beats, Revenue In Line, Shares Fall 7.5% ↗
Via Chartmill
News headline image
1 Value Stock to Target This Week and 2 We Find Risky
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
News headline image
Warren Buffett and Greg Abel Quietly Hold a Bigger Percentage of This Company Than Any Other in Berkshire's Portfolio (Hint: It's Not Apple or American Express) ↗
It's also not in the tech or finance sectors. 
Via The Motley Fool
News headline image
DaVita (DVA) Q2 2026 Earnings Call Transcript ↗
Mortality gains drove treatment growth despite payor mix headwinds. 
Via The Motley Fool
Topics Earnings
News headline image
The Top 5 Analyst Questions From DaVita’s Q2 Earnings Call
DaVita’s second quarter results surpassed Wall Street’s revenue and adjusted profit expectations, but the market response was notably negative. Management at... 
Via StockStory
Topics Earnings
Wednesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
These S&P500 stocks have an unusual volume in today's session ↗
Via Chartmill
Top S&P500 movers in Wednesday's session ↗
Via Chartmill
Which S&P500 stocks are gapping on Wednesday? ↗
Via Chartmill
News headline image
DVA Q2 Deep Dive: Flat Volumes and Policy Transitions Shape Outlook
Dialysis provider DaVita Inc. (NYSE:DVA) announced better-than-expected revenue in Q2 CY2026, with sales up 5.2% year on year to $3.55 billion. Its non-GAAP ... 
Via StockStory
Wondering what's happening in today's S&P500 pre-market session? ↗
Via Chartmill
News headline image
DaVita Q2 Earnings Call Highlights ↗
DaVita (NYSE:DVA) reported second-quarter results that management said were broadly in line with expectations, supported by accelerating treatment-volume growth and lower mortality among patients. The... 
Via MarketBeat
Topics Earnings
News headline image
DaVita (NYSE:DVA) Beats Q2 CY2026 Sales Expectations But Stock Drops
Dialysis provider DaVita Inc. (NYSE:DVA) announced better-than-expected revenue in Q2 CY2026, with sales up 5.2% year on year to $3.55 billion. Its non-GAAP ... 
Via StockStory
Discover the top S&P500 movers in Tuesday's after-hours session. ↗
Via Chartmill
Which S&P500 stocks have an unusual volume on Tuesday? ↗
Via Chartmill
News headline image
DaVita (DVA) Reports Q2: Everything You Need To Know Ahead Of Earnings
Dialysis provider DaVita Inc. (NYSE:DVA) will be reporting earnings this Tuesday afternoon. Here’s what you need to know. DaVita beat analysts’ revenue expec... 
Via StockStory
News headline image
DaVita (DVA): Buy, Sell, or Hold Post Q1 Earnings?
What a time it’s been for DaVita. In the past six months alone, the company’s stock price has increased by a massive 122%, reaching $235.17 per share. This w... 
Via StockStory
News headline image
3 S&P 500 Stocks We Think Twice About
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec... 
Via StockStory
Topics Stocks Supply Chain
News headline image
3 Unpopular Stocks Walking a Fine Line
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord... 
Via StockStory
News headline image
Everyone Is Watching Greg Abel. But Another Berkshire Hathaway Stock Picker Is Quietly Winning in 2026. ↗
Don't underestimate Ted Weschler's role in the post-Buffett era. 
Via The Motley Fool
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
DaVita vs. Encompass Health: Which Healthcare Stock Is a Better Buy in 2026? ↗
One dominates kidney care with global reach, while the other leads in rehab with faster growth and higher margins. Which business model stands out for 2026? 
Via The Motley Fool
News headline image
3 Value Stocks with Warning Signs
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t... 
Via StockStory
News headline image
Q1 Earnings Highs And Lows: DaVita (NYSE:DVA) Vs The Rest Of The Outpatient & Specialty Care Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking a... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't ↗
This particular sector may suit cautious and aggressive investors. 
Via The Motley Fool
News headline image
1 S&P 500 Stock Worth Investigating and 2 That Underwhelm
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec... 
Via StockStory
Topics Fraud Stocks
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.